|
May 1
|
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
|
|
Apr 30
|
Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics
|
|
Apr 30
|
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
|
|
Apr 18
|
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
|
|
Apr 8
|
Why Alnylam Pharmaceuticals (ALNY) Stock Might be a Great Pick
|
|
Apr 7
|
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
|
|
Mar 29
|
Those who invested in Alnylam Pharmaceuticals (NASDAQ:ALNY) five years ago are up 63%
|
|
Mar 20
|
Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Session
|
|
Mar 17
|
30 Biggest Biotechnology Companies in the World
|
|
Mar 13
|
Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease
|
|
Mar 6
|
Alnylam (ALNY), Roche's Blood Pressure Drug Meets Study Goal
|
|
Mar 5
|
Roche, Alnylam say blood pressure drug succeeds in mid-stage trial
|
|
Mar 5
|
Alnylam, Roche blood pressure drug scores in second mid-stage trial
|
|
Mar 5
|
Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
|
|
Feb 8
|
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Feb 5
|
Insider Sell: EVP, CLO & Secretary Indrani Franchini Sells 1,591 Shares of Alnylam ...
|
|
Jan 17
|
Puma Biotech (PBYI) Stock Jumps 10.0%: Will It Continue to Soar?
|
|
Jan 11
|
Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability
|
|
Jan 9
|
Alnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year by Healthcare Businesswomen’s Association
|
|
Jan 2
|
Alnylam to Webcast Presentation at 42nd Annual J.P. Morgan Healthcare Conference
|